✦ LIBER ✦
Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3
✍ Scribed by Joaquín Martínez-López; Nerea Castro; Daniel Rueda; Alicia Canal; Carlos Grande; Rosa Ayala
- Book ID
- 114714762
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 859 KB
- Volume
- 158
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.